Show simple item record

dc.contributor.authorFleck, Bettina
dc.date.accessioned2025-03-07T18:41:47Z
dc.date.available2025-03-07T18:41:47Z
dc.date.issued2024
dc.date.submitted2024-03-18T13:36:22Z
dc.identifierOCN: 1427548396
dc.identifierhttps://library.oapen.org/handle/20.500.12657/88625
dc.identifier.urihttps://doab-dev.siscern.org/handle/20.500.12854/162418
dc.description.abstractThere are fewer and fewer treatment options available for treating multi-resistant germs. In this work, peptoids were investigated as a possible class of substances for the therapeutic application of infections with multidrug-resistant bacteria, showing their antimicrobial activity against gram-positive bacteria, gram-negative bacteria, mycobacteria and fungi.
dc.languageGerman
dc.rightsopen access
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries::KNDC Chemical, biotechnology and pharmaceutical industries
dc.subject.othermultiresistent; antibacterial; antimicrobial; Peptoids; Staphlococcus Aureus; Multiresistent; Antibakteriell; Antimikrobiell; Peptoide
dc.titlePeptoide als potenzielle antibiotische Wirkstoffe gegen multiresistente Bakterien
dc.typebook
oapen.identifier.doi10.5445/KSP/1000099094
oapen.relation.isPublishedBy68fffc18-8f7b-44fa-ac7e-0b7d7d979bd2
oapen.relation.isbn9783731509868
oapen.collectionAG Universitätsverlage
oapen.pages246
peerreview.review.typeFull text
peerreview.anonymityAll identities known
peerreview.reviewer.typeInternal editor
peerreview.reviewer.typeExternal peer reviewer
peerreview.review.stagePre-publication
peerreview.open.reviewNo
peerreview.publish.responsibilityScientific or Editorial Board
peerreview.id8ad5c235-9810-49eb-b358-27c8675324d9
peerreview.titleDissertations (Dissertationen)


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

open access
Except where otherwise noted, this item's license is described as open access